Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects

by Remy Thomas, Ghaneya Al-Khadairi, Ghaneya Al-Khadairi, Julie Decock, Julie Decock
Published 2021-02-01

Cancer Testis Antigens and Immunotherapy: Where Do We Stand in the Targeting of PRAME?

by Ghaneya Al-Khadairi, Julie Decock
Published 2019-07-01

PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer

by Ghaneya Al-Khadairi, Adviti Naik, Remy Thomas, Boshra Al-Sulaiti, Shaheen Rizly, Julie Decock
Published 2019-01-01

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives

by Remy Thomas, Ghaneya Al-Khadairi, Jessica Roelands, Jessica Roelands, Wouter Hendrickx, Said Dermime, Davide Bedognetti, Julie Decock
Published 2018-05-01